Southeast Univ. CDK9 compound 8d

Southeast Univ. CDK9 compound 8d: sourced facts only. name: "Our research suggests that compound 8d, as a potent CDK9 inhibitor, can be considered as a good lead-candidate for further development." [PMID:36332552]; target: "Our research suggests that compound 8d, as a potent CDK9 inhibitor, can be considered as a good lead-candidate for further development." [PMID:36332552]; developer: "Jiangsu Province Hi-Tech Key Laboratory for Biomedical Research, Southeast University, Nanjing, 211189, China; Pharmaceutical Research Center and School of Chemistry and Chemical Engineering, Southeast University, Nanjing, 211189, Chinas." [PMID:36332552]; stage: "In vivo studies indicated that 8d exhibited potent anti-tumor effects in PANC-1 xenograft models without causing obvious loss of body weight." [PMID:36332552]